CEO William Oliver
- Date of Birth: Jun 26, 1987
- Location: London, England
- Gender: Male
Registration and Qualifications
- Primary medical qualification: BM BS 1980 The Flinders University of South Australia
- Executive Chairman, TauRx Pharmaceuticals Ltd
- Birmingham Women’s and Children’s NHS Foundation Trust
- CEO, Founder at CEN4UK.COM
- Pioneer in tau research, particularly related to Alzheimer’s and other neurodegenerative diseases
- Discoverer of the tau protein structure in Alzheimer’s tangles
ABOUT ME
SPECIALIST REGISTER
- Old age psychiatry from 30 Jun 1997
- General psychiatry from 30 Jun 1997
-
Primary medical qualification BM BS 1980 The Flinders University of South Australia from 14 Apr 1982
Registration and licensing history
From
|
To
|
Status
|
---|---|---|
16 Nov 2009 | Present | Registered with a licence to practise |
20 Oct 2005 | 16 Nov 2009 | Registered |
CLINICIAL FOCUS
- Prostate Cancer Screening
- Cystoscopy
- Neurogenic Bladder
- Congenital Kidney Disease
JOURNAL ARTICLES
Published: 06 September 2023
in International Journal of Molecular Sciences
Exploring the Anti-Hypoxaemia Effect of Hydromethylthionine: A Prospective Study of Phase 3 Clinical Trial Participants
Published: 28 June 2023
in International Journal of Molecular Sciences
Mitochondrial Effects of Hydromethylthionine, Rivastigmine and Memantine in Tau-Transgenic Mice
Published: 18 April 2023
in Cells
Utility of Blood-Based Tau Biomarkers for Mild Cognitive Impairment and Alzheimer’s Disease: Systematic Review and Meta-Analysis
Published: 18 April 2024
in Cells